🔴 Haemonetics is trading 47.5% down in after-hours trading — no reliable company-specific catalyst identified

Haemonetics is trading at $57.01, down 47.50% in after-hours trading, with no reliable company-specific announcement, earnings release, or regulatory event identified for September 22, 2026.

• Haemonetics’ investor-relations page listed first-quarter fiscal 2027 results, dated August 6, as its latest release.
• The decline contrasts with the regular-session move of -0.13%; broader market performance was mixed.
• After-hours liquidity can be thin, so the quote may warrant rechecking.